sec.234Notification about pathological examination

### sec.234 Notification about pathological examination This section applies to the director of a pathology laboratory if— a pathological examination of a specimen of human origin is carried out at the laboratory; and either— the examination indicates the person from whom the specimen was taken has, or has had, cancer; or the director reasonably suspects the examination is a cancer-related follow-up examination. The director must, within the period prescribed by regulation, give the chief executive a notification in the approved form about the pathological examination. Maximum penalty—20 penalty units. In this section— cancer-related follow-up examination means a pathological examination of a specimen of human origin that is— carried out after the person from whom the specimen was taken has been diagnosed with cancer; and carried out— to determine the characteristics or status of the cancer; or to support or inform the treatment of the cancer. s 234 sub 2023 No. 9 s 21 (sec.234-ssec.1) This section applies to the director of a pathology laboratory if— a pathological examination of a specimen of human origin is carried out at the laboratory; and either— the examination indicates the person from whom the specimen was taken has, or has had, cancer; or the director reasonably suspects the examination is a cancer-related follow-up examination. (sec.234-ssec.2) The director must, within the period prescribed by regulation, give the chief executive a notification in the approved form about the pathological examination. Maximum penalty—20 penalty units. (sec.234-ssec.3) In this section— cancer-related follow-up examination means a pathological examination of a specimen of human origin that is— carried out after the person from whom the specimen was taken has been diagnosed with cancer; and carried out— to determine the characteristics or status of the cancer; or to support or inform the treatment of the cancer. - (a) a pathological examination of a specimen of human origin is carried out at the laboratory; and - (b) either— (i) the examination indicates the person from whom the specimen was taken has, or has had, cancer; or (ii) the director reasonably suspects the examination is a cancer-related follow-up examination. - (i) the examination indicates the person from whom the specimen was taken has, or has had, cancer; or - (ii) the director reasonably suspects the examination is a cancer-related follow-up examination. - (i) the examination indicates the person from whom the specimen was taken has, or has had, cancer; or - (ii) the director reasonably suspects the examination is a cancer-related follow-up examination. - (a) carried out after the person from whom the specimen was taken has been diagnosed with cancer; and - (b) carried out— (i) to determine the characteristics or status of the cancer; or (ii) to support or inform the treatment of the cancer. - (i) to determine the characteristics or status of the cancer; or - (ii) to support or inform the treatment of the cancer. - (i) to determine the characteristics or status of the cancer; or - (ii) to support or inform the treatment of the cancer.